BSW Wealth Partners lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 6.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,556 shares of the medical equipment provider’s stock after acquiring an additional 90 shares during the quarter. BSW Wealth Partners’ holdings in Intuitive Surgical were worth $812,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. State Street Corp boosted its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC grew its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after acquiring an additional 143,440 shares in the last quarter. Fisher Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after acquiring an additional 86,208 shares during the last quarter. Finally, Baillie Gifford & Co. boosted its stake in shares of Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
ISRG has been the subject of several recent research reports. Barclays upped their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday. Mizuho increased their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Robert W. Baird lifted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday. Finally, CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday. They issued a “neutral” rating and a $550.00 target price on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.
Insider Activity
In related news, insider Jamie Samath sold 22,903 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 28,749 shares of company stock worth $15,303,875. Insiders own 0.90% of the company’s stock.
Intuitive Surgical Price Performance
Shares of NASDAQ ISRG opened at $574.14 on Wednesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a 50-day moving average of $548.00 and a 200 day moving average of $506.12. The stock has a market cap of $204.50 billion, a P/E ratio of 92.31, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- P/E Ratio Calculation: How to Assess Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How is Compound Interest Calculated?
- What Does the Future Hold for Eli Lilly?
- The 3 Best Retail Stocks to Shop for in August
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.